PDZK3 Activators
PDZK3 Activators constitute a diverse assembly of chemical compounds that bolster the functional dynamics of PDZK3 through various intracellular signaling mechanisms. Phosphatidic Acid and Sphingosine-1-Phosphate elevate PDZK3's activity by acting on lipid signaling pathways, with the former enhancing mTOR pathway interactions and the latter engaging G protein-coupled receptors, potentially leading to the activation of Rho GTPases. Forskolin, Isoproterenol, and IBMX collectively contribute to PDZK3 activation by increasing cellular cAMP levels, subsequently activating protein kinase A (PKA) which could phosphorylate PDZK3 or associated substrates. The action of U73122, by inhibiting phospholipase C, may enhance PDZK3's functional role by modifying DAG and IP3 levels, thus shifting signaling towards PDZK3-related pathways. Ceramide, through its role in activating protein phosphatases, and Ionomycin, by increasing intracellular calcium and potentially activating CaMK, could both alter the phosphorylation landscape in a manner that promotes PDZK3's involvement in signaling.
In parallel, the PDZK3 landscape is modulated by compounds such as LY294002, which, by inhibiting PI3K, could reroute cellular signaling through PDZK3-engaged pathways. FTY720, by modulating S1P receptors, may augment PDZK3's role in GTPase-mediated signaling processes. Furthermore, the direct activation of protein kinase C (PKC) by Diacylglycerol (DAG) and Phorbol 12-myristate 13-acetate (PMA) might lead to the phosphorylation of proteins within PDZK3-associated signaling pathways, thereby enhancing the scaffold protein's functional activity. These PDZK3 Activators, through targeted biochemical interactions, potentiate the signaling pathways and cellular processes in which PDZK3 is implicated, without necessitating an increase in its expression or direct activation of the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-α-Lecithin, Egg Yolk, Highly Purified | 8002-43-5 | sc-203096 | 250 mg | $135.00 | ||
Phosphatidic acid acts as a lipid second messenger which can activate the mTOR signaling pathway. PDZK3 has been suggested to interact with components of mTOR signaling, and through this pathway, Phosphatidic Acid could enhance PDZK3 activity by facilitating its interaction within the pathway. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages G protein-coupled receptors and may activate the Rho family of GTPases. Given that PDZK3 interacts with multi-domain scaffold proteins, it is plausible that S1P may enhance PDZK3 activity by promoting scaffolding functions that facilitate signal transduction. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn activates PKA. PKA phosphorylation can lead to the activation of proteins through conformational changes. PDZK3, being a scaffold protein, could be functionally enhanced by PKA-mediated phosphorylation events. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide can initiate a variety of signaling cascades, including the activation of protein phosphatases. Through the modulation of these phosphatases, ceramide may enhance PDZK3's role by affecting the phosphorylation status of proteins within the pathways PDZK3 is associated with. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calmodulin-dependent protein kinases (CaMK). These kinases could then enhance PDZK3 activity by modulating proteins that interact with PDZK3 in calcium-dependent signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter AKT signaling. By inhibiting PI3K, LY294002 could shunt signaling through alternative pathways that may include PDZK3, indirectly enhancing its activity by promoting its involvement in PI3K/AKT-independent processes. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels. This elevation may enhance PDZK3 activity by cAMP-dependent protein kinase-mediated signaling pathways, which could phosphorylate targets associated with PDZK3. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine-1-phosphate receptor modulator that can affect various signaling pathways, including those involving GTPases. PDZK3's potential role in cellular signaling could be enhanced by FTY720 through pathways modulated by S1P receptor engagement. | ||||||